Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04178122 · ClinicalTrials.gov registry record · NA

Million Veteran Program Return of Actionable Results

A NA study of Cardiovascular Disease, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT04178122 is a NA study of Cardiovascular Disease that has completed, run by VA Office of Research and Development. The registered enrollment target is 112 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04178122, a NA study of Cardiovascular Disease, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

The purpose of the Million Veteran Program- Return of Actionable Results (MVP-ROAR) Study is to develop a process to return medically actionable genetic results to living MVP participants nationwide and to determine the impact of doing so on medical management and outcomes and Veteran quality of life.

Conditions Studied

Interventions

  • GENETIC Result disclosure

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2020-02-27
Est. Completion 2024-09-08
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04178122

The ClinicalTrials.gov registry entry for NCT04178122 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (96% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Result disclosure is the first listed.

NCT04178122 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04178122 about?

NCT04178122 is a clinical study titled "Million Veteran Program Return of Actionable Results". The purpose of the Million Veteran Program- Return of Actionable Results (MVP-ROAR) Study is to develop a process to return medically actionable genetic results to living MVP participants nationwide and to determine the impact of doing so on medical management and outcomes and Veteran quality of lif...

What is the current status of trial NCT04178122?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2020-02-27. Estimated completion is 2024-09-08.

What conditions does trial NCT04178122 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT04178122?

The interventions under investigation include: Result disclosure (GENETIC).

Who is sponsoring clinical trial NCT04178122?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04178122 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.